Literature DB >> 16014968

Reduced prevalence of Epstein-Barr virus-related lymphocryptovirus infection in sera from a new world primate.

Mark H Fogg1, Angela Carville, Jennifer Cameron, Carol Quink, Fred Wang.   

Abstract

The recent discovery of an Epstein-Barr virus (EBV)-related lymphocryptovirus (LCV) naturally infecting common marmosets demonstrated that gamma-1 herpesviruses are not limited to human and Old World nonhuman primate hosts. We developed serologic assays to detect serum antibodies against lytic- and latent-infection marmoset LCV antigens in order to perform the first seroepidemiologic study of LCV infection in New World primates. In three different domestic colonies and in animals recently captured from the wild, we found that the seroprevalence of marmoset LCV infection was not as ubiquitous as with EBV or Old World LCV. These biologic differences in LCV infection of New World versus human and Old World primate hosts correlate with the evolution of the LCV viral gene repertoire.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014968      PMCID: PMC1181547          DOI: 10.1128/JVI.79.15.10069-10072.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

Review 1.  Epstein-Barr virus and nonhuman primates: natural and experimental infection.

Authors:  A Frank; W A Andiman; G Miller
Journal:  Adv Cancer Res       Date:  1976       Impact factor: 6.242

2.  Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins.

Authors:  W M van Grunsven; E C van Heerde; H J de Haard; W J Spaan; J M Middeldorp
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

3.  Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of epithelial cells.

Authors:  C M Borza; L M Hutt-Fletcher
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

4.  An Epstein-Barr-related herpesvirus from marmoset lymphomas.

Authors:  Y Cho; J Ramer; P Rivailler; C Quink; R L Garber; D R Beier; F Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

5.  Seroepidemiologic studies of Epstein-Barr virus antibody in monkeys.

Authors:  J C Landon; L B Malan
Journal:  J Natl Cancer Inst       Date:  1971-04       Impact factor: 13.506

6.  Identification and molecular characterization of two diagnostically relevant marker proteins of the Epstein-Barr virus capsid antigen complex.

Authors:  W M van Grunsven; A Nabbe; J M Middeldorp
Journal:  J Med Virol       Date:  1993-06       Impact factor: 2.327

7.  Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections.

Authors:  P Rao; H Jiang; F Wang
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

8.  Epidemiology of herpesvirus papio infection in a large captive baboon colony: similarities to Epstein-Barr virus infection in humans.

Authors:  H B Jenson; Y Ench; S J Gao; K Rice; D Carey; R C Kennedy; J R Arrand; M Mackett
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

9.  Detection of human serum antibodies to the BFRF3 Epstein-Barr virus capsid component by means of a DNA-binding assay.

Authors:  D Shedd; A Angeloni; J Niederman; G Miller
Journal:  J Infect Dis       Date:  1995-11       Impact factor: 5.226

10.  Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein.

Authors:  W M van Grunsven; W J Spaan; J M Middeldorp
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

View more
  5 in total

1.  Identification and functional comparison of seven-transmembrane G-protein-coupled BILF1 receptors in recently discovered nonhuman primate lymphocryptoviruses.

Authors:  Katja Spiess; Suzan Fares; Alexander H Sparre-Ulrich; Ellen Hilgenberg; Michael A Jarvis; Bernhard Ehlers; Mette M Rosenkilde
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

Review 2.  Nonhuman primate models for Epstein-Barr virus infection.

Authors:  Fred Wang
Journal:  Curr Opin Virol       Date:  2013-04-03       Impact factor: 7.090

3.  Comparative pathobiology of macaque lymphocryptoviruses.

Authors:  Angela Carville; Keith G Mansfield
Journal:  Comp Med       Date:  2008-02       Impact factor: 0.982

4.  The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II.

Authors:  Laura L Quinn; Luke R Williams; Claire White; Calum Forrest; Jianmin Zuo; Martin Rowe
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

5.  A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates.

Authors:  Andrew D Hislop; Maaike E Ressing; Daphne van Leeuwen; Victoria A Pudney; Daniëlle Horst; Danijela Koppers-Lalic; Nathan P Croft; Jacques J Neefjes; Alan B Rickinson; Emmanuel J H J Wiertz
Journal:  J Exp Med       Date:  2007-07-09       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.